2m 2m 2m 2m 2m 2m 2m
PULMONX (LUNG)
NASDAQ
$1.28+$0.004 (+0.31%)
Price as of Jun 23, 2026 7:55 PM EDT- $54.1MMarket Cap
- -52.50%1-Year Change
- Medical DevicesIndustry
PULMONX (LUNG)
$1.28+$0.004 (+0.31%)
LUNG | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.28 | ||
Change | +$0.01 (+0.79%) | ||
Open | $1.25 | ||
High | $1.30 | ||
Low | $1.25 | ||
Previous Close | $1.27 | ||
Volume | 399,791 | ||
30-Day Average Volume | 363,079 | ||
1-Week Change | 2.40% | ||
1-Month Change | -17.42% | ||
1-Year Change | -52.50% | ||
3-Year Change | -90.06% | ||
5-Year Change | -97.09% | ||
Fundamentals | |||
Shares Outstanding | 42.2M | ||
Total Assets | $120.0M | ||
Market Cap | $54.1M | ||
Enterprise Value | $29.8M | ||
Period: QTR TTM FY | |||
Revenue | $20.6M | ||
Net Income | -$13.7M | ||
Free Cash Flow | -$10.1M | ||
EBIT | -$13.3M | ||
EBITDA | -$13.1M | ||
Net Working Capital | $73.8M | ||
EPS | -$0.33 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | 1 | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue